Cumberland Pharmaceuticals, Inc. (CPIX)
6.80
+0.18
(+2.72%)
USD |
NASDAQ |
Sep 09, 09:57
Cumberland Pharmaceuticals Enterprise Value : 99.71M for Sept. 8, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 08, 2026 | 99.71M |
| September 04, 2026 | 102.26M |
| September 03, 2026 | 101.66M |
| September 02, 2026 | 98.21M |
| September 01, 2026 | 98.81M |
| August 31, 2026 | 100.76M |
| August 28, 2026 | 127.28M |
| August 27, 2026 | 130.12M |
| August 26, 2026 | 134.92M |
| August 25, 2026 | 130.87M |
| August 24, 2026 | 117.99M |
| August 21, 2026 | 115.14M |
| August 20, 2026 | 112.89M |
| August 19, 2026 | 115.14M |
| August 18, 2026 | 114.84M |
| August 17, 2026 | 115.59M |
| August 14, 2026 | 117.24M |
| August 13, 2026 | 118.89M |
| August 12, 2026 | 119.04M |
| August 11, 2026 | 119.79M |
| August 10, 2026 | 117.24M |
| August 07, 2026 | 117.39M |
| August 06, 2026 | 115.59M |
| August 05, 2026 | 113.64M |
| August 04, 2026 | 116.94M |
| Date | Value |
|---|---|
| August 03, 2026 | 108.10M |
| July 31, 2026 | 100.61M |
| July 30, 2026 | 101.36M |
| July 29, 2026 | 100.31M |
| July 28, 2026 | 102.56M |
| July 27, 2026 | 105.85M |
| July 24, 2026 | 99.56M |
| July 23, 2026 | 105.18M |
| July 22, 2026 | 107.12M |
| July 21, 2026 | 118.14M |
| July 20, 2026 | 109.90M |
| July 17, 2026 | 103.00M |
| July 16, 2026 | 115.29M |
| July 15, 2026 | 117.39M |
| July 14, 2026 | 105.18M |
| July 13, 2026 | 98.51M |
| July 10, 2026 | 89.37M |
| July 09, 2026 | 91.02M |
| July 08, 2026 | 94.16M |
| July 07, 2026 | 94.76M |
| July 06, 2026 | 92.82M |
| July 02, 2026 | 95.96M |
| July 01, 2026 | 107.35M |
| June 30, 2026 | 97.61M |
| June 29, 2026 | 101.21M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Johnson & Johnson | 676.38B |
| Eli Lilly & Co. | 1.104T |
| ANI Pharmaceuticals, Inc. | 1.848B |
| Corcept Therapeutics, Inc. | 12.00B |
| Veru, Inc. | 20.88M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.104M |
| Revenue (Quarterly) | 0.1665M |
| Total Expenses (Quarterly) | 3.273M |
| EPS Diluted (Quarterly) | -0.2854 |
| Profit Margin (Quarterly) | -1.86K% |
| Earnings Yield | -10.73% |
| Normalized Earnings Yield | -10.47 |